Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
glycerin + polyethylene glycol 400
- Development stage
- Unknown
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
**Glycerin + polyethylene glycol 400** is a topical ophthalmic lubricant combination used in artificial-tear products for temporary relief of burning, irritation, and discomfort associated with dry eye. Glycerin and polyethylene glycol 400 act as demulcent lubricants that retain moisture and form a protective film over the ocular surface, reducing friction and helping protect the eye from further environmental irritation. The exact two-ingredient name does not identify a single standardized branded product; many labeled artificial-tear products containing these ingredients also contain hypromellose as a third active lubricant. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c62432b-bd6d-46ac-a5fb-8dadfda04846))
- Other names
- glycerin + PEG 400glycerin + polyethylene glycol 400glycerol + polyethylene glycol 400polyethylene glycol 400 + glycerin
Beyond the preview
Go deeper on glycerin + polyethylene glycol 400.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on glycerin + polyethylene glycol 400.